Sort   by:  
 Page size 
UnknownEarly versus late oral anticoagulation after mild to moderate AIS in AF patients: Insights from real-world data.
Not available
S-EPMC12517804 | biostudies-literature
UnknownReal-world effectiveness of SGLT2 inhibitors in patients with HF and ESKD: a multicenter cohort study.
Not available
S-EPMC12856922 | biostudies-literature
UnknownAssociation between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes: a propensity-matched cohort study.
Not available
S-EPMC12557926 | biostudies-literature
UnknownMajor adverse kidney events among chronic kidney disease patients with vitamin D deficiency.
Not available
S-EPMC12537428 | biostudies-literature
UnknownDiagnostic utility and pitfalls of human T-lymphotropic virus serology in adult T-cell leukemia/lymphoma: evidence from a 25-year pathology-based nonendemic cohort.
Not available
S-EPMC12748522 | biostudies-literature
UnknownLaboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan.
Not available
S-EPMC1081360 | biostudies-literature
UnknownMetformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Not available
S-EPMC11261235 | biostudies-literature
UnknownNationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Not available
S-EPMC8648748 | biostudies-literature
UnknownEffectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Not available
S-EPMC10042416 | biostudies-literature
UnknownArtificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Not available
S-EPMC10776298 | biostudies-literature
Sort   by:  
 Page size